期刊文献+

妊娠合并HELLP综合征发病机理的新进展 被引量:4

Advance in research on pathogenesis of pregnancy-induced HELLP syndrome
下载PDF
导出
摘要 HELLP综合征是产科严重并发症之一 ,它可能是一种独立的疾病 ,也可能是先兆子痫的严重并发症形式 ,其发病机理目前尚不清楚。现将HELLP综合征发生的有关因素进行综述 。 HELLP syndrome is one of severe obstetric complications, which may be an independent disease or severe complication of preeclampsia, and its pathogenesis is incompletely clear till now. In this article, we summarized the relating factors by which HELLP syndrome occur, so as to provide reliable basis for early laboratory examination and gene therapy of the disease.
出处 《国外医学(妇幼保健分册)》 2003年第6期346-348,共3页 Foreign Medical Sciences (Section of Maternal and Child Health)
关键词 HELLP综合征 发病机制 凝血因子V 长链-3-羟酰CoA脱氢酶 血清瘦素 HELLP syndrome pathogenesis coagulation factor V long chain 3 hydroxyacyl coA dehydrogenase serum leptin
  • 相关文献

参考文献16

  • 1[1]Dahlback B. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis[J]. Thromb Haemost, 1997,78(4): 1298 - 1299.
  • 2[2]Bloomenthal D, Dadelszen P, Liston R, et al. The effect of factor V Leiden carriage on maternal and fetal health [J].CAMJ,2002,167(1) :48 - 54.
  • 3[3]Bozzo M, Carpani G, Leo L, et al. HELLP syndrome and factor V Leiden[J]. Eur J Obstet Repord Biol,2001,95( 1):55- 58.
  • 4[4]Svensson P J, Zoller B, Matlasson J, et al. The factor VR506Q mutation causing APC resistant is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis[J[. J Intern Med,1997,241(5) :379 - 385.
  • 5[5]Krauss T, Augustin H G, Osmers R, et al. Activated protein C resistance and factor V Leiden tn patients with hemolysis, elevated liver enzymes, low platelets syndrome[ J ]. Obstet Gynecol, 1998,92(3) :457 - 460.
  • 6[6]Pampus M G, Wolf H, Koopman M M, et al. Prothrombin 20210G: a mutation and Factor V Leiden mutation in woman with a history of severe preeclampsia and (H)ELLP syndrome[J]. Hypertens Pregancy,2001,20(3) :291 - 298.
  • 7[7]Benedetto C, Marozio L, Salton L, et al. Factor V Leiden and factor Ⅱ G20210A in preeclampsia and HELLP syndrome[ J ].Acta Obstet Gynecol Scand,2002,81 (12): 1095 - 1100.
  • 8[8]Bussen S, Sutterlin M, Steck T. Plasma endothelin and big endothelin levels in women with severe preeclampsia or HELLP-syndrome[J]. Arch Gynecol Obstet, 1999,262(3 - 4) :113 - 119.
  • 9[9]Boer M E, Wanders R J, Morris A A, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients [ J ]. Pediatrics, 2002,109 ( 1 ):99 - 104.
  • 10[10]Ibdah J A, Yang Z, Bennett M J. Liver disease in pregnancy and fetal fatty acid oxidation defects[ J ]. Mol Genet Metab,2000,71( 1 - 2): 182 - 189.

同被引文献11

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部